Announcements

Default Banner

Testing Pentobarbital

DYNALABS Honored

On July 10, 2020, an article from a Reuters reporter appeared in the news indicating DYNALABS had unknowingly been testing pentobarbital, a medication that was compounded for use in executions.  This medication is commonly used to help with sleep disorders, in anesthesia, and to help shrink brain tissue subsequent to severe head trauma. Several years ago, DYNALABS was asked to test pentobarbital for lethal injection for a penal system.  We refused to do so, because…

Read More


Top 10 Secure Computing Tips

10 tips for better cyber security

With the ever rising threat of cyber-crimes and phishing attempts, DYNALABS would like to share some information with you. Here are 10 tips to help avoid cyber-security issues. Tip #1 – You are a target to hackers We are all at risk and the stakes are high – to your personal and financial well-being. Keeping our computing resources secure is everyone’s responsibility. By following the tips below and remaining vigilant, you are doing your part…

Read More


Updated API methods | Ephedrine Sulfate, Ascorbic Acid, Diltiazem, Ketamine

DYNALABS Honored

As part of our dedication to continuous quality improvement, DYNALABS is constantly creating new, and updating existing, API Potency test methods. Now available, our updated API methods for Ephedrine Sulfate, Ascorbic Acid, Diltiazem, Ketamine These updated methods are available Tuesday May 26th, 2020 If you need additional information, please contact us at info@dynalabs.us or reach out to your dedicated Sales Representative.

Read More


Glutathione Method Update!

DYNALABS Honored

Now available for use on our updated UHPLC method. This method can be utilized for routine testing and beyond use date studies.

Glutathione is now available as an upgraded UHPLC method and can be utilized for routine testing and beyond use date studies. Our validation meets ICH Q2(R1) and USP <1225>. Criteria. This method was created with our innovation and utilizing years of research and development.

Read More


CONTINUING ESSENTIAL SERVICES

DYNALABS Honored

DYNALABS remains committed to maintaining a safe and healthy work environment for our employees, so that they continue to help our clients achieve our primary guiding principle of patient safety. With St. Louis situated on the Missouri / Illinois border, our employees are impacted by events in both states.  Over the past week, the Mayor of St. Louis City, the St. Louis County Executive, and Illinois’ Governor, implemented Stay at Home orders for the St….

Read More


DYNALABS joins forces with Mayo Clinic to help hospitals prevent medication diversion

DYNALABS-MAYO-ANiGENT

FOR IMMEDIATE RELEASE FOR ADDITIONAL INFORMATION, CALL Marita Gomez, 630-936-9105 maritag@crispsolution.net Duska Anastasijevic, Mayo Clinic Public Affairs newsbureau@mayo.edu St. Louis, Mo., March 17, 2020 — DYNALABS and Mayo Clinic have joined forces to launch ANiGENT, a new company whose proprietary software uses machine learning to deliver a state-of-the-art drug diversion surveillance system. The novel platform will help hospitals and health systems reduce patient and worker harm from potential drug diversion and prevent regulatory or legal…

Read More


SAFETY DURING THE COVID-19 OUTBREAK

DYNALABS Honored

Valued Customers, DYNALABS is committed to maintaining a safe and healthy environment for our employees, so that they may continue to achieve our primary guiding principle of patient safety.  We achieve this by servicing our customers’ testing needs, so that our clients may in turn service their patient’s need for safe and effective medications.  To accomplish this goal we have implemented the following policies: We have suspended any non-essential business travel by mass transit (air,…

Read More


DYNALABS PARTNERS HONORED by WEBSTER UNIVERSITY

DYNALABS Honored

Michael Pruett, CEO & Managing Partner DYNALABS LLC, and V.C. “Jun” Fabella Jr., EVP & Partner  DYNALABS LLC, are being honored as Outstanding Alumnus for the George Herbert Walker School of Business & Technology.  The award recognizes alumni who have achieved outstanding success and recognition in their profession. Both Michael and Jun received their MBAs from the Webster University in 1994. Award Honorees are invited to attend the President’s Commencement dinner on Friday, May 10th…

Read More


DYNALABS ANNOUNCES FORMATION OF THE“DYNALABS NEW VENTURES INITIATIVE”

For Immediate Release, ST. LOUIS, MO, April 22, 2019 – DYNALABS is excited to announce the formation of the DYNALABS New Ventures Initiative (DNVI). This new initiative will be led by Jun Fabella. In his new role as Executive Vice President of DNVI, Jun will be responsible for identifying and executing on the viability and commercial value of unique business opportunities and innovations. Over our exciting fifteen-year history, DYNALABS has often been presented with unique…

Read More


DYNALABS welcome consulting group AMICUS cGMP

DYNALABS announces today that its consulting division has separated into the independent consulting group, AMICUS cGMP Consultants.  New CEO & Principal Consultant, Kristopher Le, is based in Lexington, SC, and he assures everyone that AMICUS Consultants will continue to work with DYNALABS, LLC. AMICUS’ mission is to offer consulting services to pharmaceutical compounders and manufacturers, thus improving the overall safety and quality of their products.  While AMICUS and DYNALABS will cooperate strategically, the separation into different business…

Read More